Expand LXRX Menu
LXRX MENU

LXRX Stock Summary and Trading Ideas (Lexicon Pharmaceuticals | NASDAQ:LXRX)

Charts for Today's Stock Price and Implied Volatility in Lexicon Pharmaceuticals

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for LXRX by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Lexicon Pharmaceuticals (LXRX) Frequently Asked Questions

What does Lexicon Pharmaceuticals do?

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

What symbol and exchange does Lexicon Pharmaceuticals shares trade?

Lexicon Pharmaceuticals trades on the NASDAQ stock market under the symbol LXRX.

What is Lexicon Pharmaceuticals stock price doing today?

As of November 22, 2024, LXRX stock price climbed to $0.86 with 9,075,904 million shares trading.

What is Lexicon Pharmaceuticals's Beta?

LXRX has a beta of 2.83, meaning it tends to be more sensitive to market movements. LXRX has a correlation of 0.12 to the broad based SPY ETF.

How much is Lexicon Pharmaceuticals worth?

LXRX has a market cap of $312.11 million. This is considered a Small Cap stock.

How much money does Lexicon Pharmaceuticals make?

Last quarter Lexicon Pharmaceuticals reported $2 million in Revenue and -$.18 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.02.

What is the highest and lowest price Lexicon Pharmaceuticals traded in the last 3 year period?

In the last 3 years, LXRX traded as high as $5.22 and as low as $.73.

What are the top ETFs holding Lexicon Pharmaceuticals?

The top ETF exchange traded funds that LXRX belongs to (by Net Assets): VTI, VXF, IWM, VTWO, SCHA.

Is Lexicon Pharmaceuticals (LXRX) a good investment?

LXRX has underperformed the market in the last year with a price return of -20.1% while the SPY ETF gained +32.9%. LXRX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -54.8% and -33.6%, respectively, while the SPY returned +6.5% and 0.0%, respectively.

What are the support and resistance levels for Lexicon Pharmaceuticals (LXRX)?

LXRX support price is $.72 and resistance is $.82 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LXRX shares will trade within this expected range on the day.